Clin2
NCT07238790Possibly a fitNot yet recruiting

Bacteria treatment for diarrhea-type irritable bowel syndrome

IBS (Irritable Bowel Syndrome)Diarrhea

Part of Digestive system clinical trials.

This trial tests a new treatment made from a mix of bacteria that live in the gut. It aims to improve symptoms of irritable bowel syndrome with diarrhea (IBS-D) in people who have certain gut bacteria imbalances.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
13 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a diagnosis of IBS with diarrhea (IBS-D).
  • You have a certain type of gut bacteria imbalance, like high bile acid in stool or a positive breath test.
  • Your gallbladder is present and you have no history of major gut surgery.
  • You are willing to use birth control during the treatment and for one week after if you are of childbearing age.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07172139Not yet recruiting
Brain stimulation and gut treatments for diarrhea-predominant IBS

This trial tests whether combining brain stimulation (called transcranial magnetic stimulation) with either a medication or a probiotic can help reduce diarrhea and belly pain in people with IBS. If you join, you'll receive one of these combinations to see if it improves your symptoms.

NCT05776914Recruiting· Phase 2
Fecal transplant to treat moderate to severe IBS symptoms

This trial tests whether putting stool (fecal microbiota) from a donor into your bowel can improve symptoms in people with IBS who are not IBS-C. It may help by changing the gut bacteria that can influence IBS symptoms.

Rochester, Minnesota
NCT06636513Recruiting
Testing SMT04 for irritable bowel syndrome

This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.

Singapore, Singapore
NCT07872514Enrolling by invitation
Personalized probiotics for irritable bowel syndrome

This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.

Hamilton, Ontario
NCT07475299Not yet recruiting
Gut health supplement for irritable bowel syndrome

This study tests a daily supplement containing beneficial bacteria (synbiotic) and plant extracts to improve gut health and reduce symptoms of irritable bowel syndrome (IBS), such as bloating, gas, and changes in bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.

Cluj-Napoca
NCT06433180Not yet recruiting· Phase 3
Fecal transplant for severe irritable bowel syndrome

This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.

Bobigny

Hear when a new Diarrhea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.